Aristo Bio-Tech and Lifescience (NSE:ARISTO) Scaled Net Operating Assets : 0.45 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Aristo Bio-Tech and Lifescience Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aristo Bio-Tech and Lifescience's operating assets for the quarter that ended in Sep. 2024 was ₹2,225 Mil. Aristo Bio-Tech and Lifescience's operating liabilities for the quarter that ended in Sep. 2024 was ₹1,648 Mil. Aristo Bio-Tech and Lifescience's Total Assets for the quarter that ended in Mar. 2024 was ₹1,273 Mil. Therefore, Aristo Bio-Tech and Lifescience's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.45.

Aristo Bio-Tech and Lifescience Scaled Net Operating Assets Historical Data

The historical data trend for Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aristo Bio-Tech and Lifescience Scaled Net Operating Assets Chart

Aristo Bio-Tech and Lifescience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

0.36

0.40

0.49

0.66

0.54

Aristo Bio-Tech and Lifescience Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial			0.59	0.47	0.56	0.42	0.45

Competitive Comparison of Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets

For the Agricultural Inputs subindustry, Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Aristo Bio-Tech and Lifescience Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(1266.749	-	728.025)	/	998.292
=	0.54

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1272.87	-	6.121
=	1266.749

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	936.784	-	99.964	-	108.795
=	728.025

Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(2225.026	-	1648.079)	/	1272.87
=	0.45

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2232.833	-	7.807
=	2225.026

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1851.213	-	84.781	-	118.353
=	1648.079

Aristo Bio-Tech and Lifescience Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Aristo Bio-Tech and Lifescience's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Aristo Bio-Tech and Lifescience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Aristo Bio-Tech and Lifescience Ltd (NSE:ARISTO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775

Website

https://www.aristobiotech.com

Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.

Aristo Bio-Tech and Lifescience Headlines

No Headlines